Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Methotrexate in Tubal Ectopic Pregnancy
NCT06426979Completed
- Sponsor
- Zagazig University
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of letrozole in Ectopic pregnancy (EP), sponsored by Zagazig University. Primary endpoint: Rate of resolution of Tubal Ectopic Pregnancy at 9 months. Started Jan 2023; status: completed.
02
Drugs
letrozole
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT06426979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06426979.